NCT06830122

Effects of Lactobacillus Crispatus LCr86 on Bacterial Vaginosis and Ovarian Function in Women

Effects of Lactobacillus Crispatus LCr86 on Bacterial Vaginosis and Ovarian Function in Women: a Randomized, Double-blind, Placebo-controlled Trial

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Lactobacillus crispatus LCr86 was selected as a test preparation to observe its clinical efficacy in an intervention trial of combined antibiotic treatment and evaluate its effect on the cure rate, recurrence rate and vaginal flora of patients with bacterial vaginitis.

Conditions

• Patients With Bacterial Vaginosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The experimental phase of this study will last 8 weeks and each subject will receive 4 follow-up visits (week 0, week 4, week 8, week 20).
DIETARY_SUPPLEMENT	Placebo	The experimental phase of this study will last 8 weeks and each subject will receive 4 follow-up visits (week 0, week 4, week 8, week 20).

Timeline

• Start date: 2025-03-20
• Primary completion: 2025-09-30
• Completion: 2026-04-30
• First posted: 2025-02-17
• Last updated: 2025-02-17